Categories: News

Cofertility’s “State of Egg Freezing 2024” Report Reveals 30% Increase in Egg Freezing Cycles Year-Over-Year

LOS ANGELES–(BUSINESS WIRE)–Cofertility, the human-centered fertility ecosystem offering a scalable approach to egg freezing and third-party reproduction, this week announced the release of its comprehensive report, “State of Egg Freezing 2024.” This report provides an in-depth analysis of the latest trends, motivations, and advancements in the field of egg freezing, highlighting a significant 30% year-over-year increase in egg freezing cycles.


The report explores the shifting motivations driving this increase, emphasizing the changing societal norms and greater acceptance of egg freezing as a viable option for women who wish to delay childbirth. Key factors contributing to this trend include career aspirations, educational goals, and the desire for later-life family planning. Additionally, the report details how technological advancements have played a crucial role in enhancing the success rates of egg freezing procedures, making them more accessible and reliable than ever before.

Key Findings of the Report:

  • Significant Growth in Demand: Demand for egg freezing is soaring, with a 30% year-over-year increase in cycles. This reflects changing priorities and greater acceptance of the procedure, but there’s still substantial room for growth as financial barriers are addressed, medical technology advances and societal acceptance further solidifies egg freezing as a mainstream fertility preservation option.
  • Evolving Priorities: Motivations for egg freezing evolve with age. Initially, the focus is on career and education. Later, finding a partner becomes more important. While priorities remained broadly consistent across geographies, subtle variations emerged based on where women lived. In larger cities, there is more of an emphasis on prioritizing career advancement and education and greater uncertainty about wanting kids altogether.
  • A Broader Trend of “Later” Parenthood: While innovations in egg freezing technology, greater visibility through media coverage and changing social climates may have played a significant role in driving the increase in egg freezing demand, there has also been a universal increase in the relevance of egg freezing for those desiring the option for biological children “later” in life. This trend reflects a broader societal shift towards later marriage and parenthood.

The “State of Egg Freezing 2024” report was developed in response to the recently released 2022 assisted reproductive technology (ART) data from the Society for Assisted Reproductive Technology (SART), which was published in April 2024. The SART data highlighted trends in ART procedures, prompting Cofertility to survey 75,000+ respondents ages 20-45 from August 2022 to April 2024 to further examine the societal implications and motivations driving demand.

The report was authored by Cofertility Co-Founder Halle Tecco, MPH, MBA, alongside medical advisors Dr. Meera Shah, MD, FACOG, a double board-certified OBGYN and reproductive endocrinology and fertility specialist at NOVA IVF in Mountain View, California, and Dr. Mare Mbaye, MD, a board-certified OBGYN based in New York City.

Accessing the Report:

For more detailed information and to access the full “State of Egg Freezing 2024” report, please visit Cofertility’s website.

For more information and to learn about affordable, and even free, egg freezing, visit cofertility.com.

About Cofertility

Cofertility is reshaping fertility preservation and third-party reproduction so it’s more accessible, human and community-driven. The company offers a destigmatized, scalable approach to egg donation, which reshapes the cost structure of egg-freezing by matching women who want to freeze their eggs with families who could not otherwise conceive and by donating half, women can freeze their eggs for free. Cofertility is in the “family” business, determined to improve the family-building journey — today or in the future — and is in an endless pursuit to make these experiences more positive. For more information, visit www.cofertility.com or follow on LinkedIn and Instagram.

Contacts

Morgan Bellock

President, MB Public Relations

E: Morgan@mbpublicrelations.com
P: 734.730.3413

Staff

Recent Posts

BioSonic Bloom: What Published Research Says About 528 Hz and 432 Hz Audio Frequency Programs

An In-Depth Analysis of Digital Sound Frequency Programs, Binaural Beats Research, and Key Considerations for…

19 hours ago

Best TRT Injection for 2026: Fridays Lists Prescription Testosterone in Injectable and Oral Formats as Men Compare Telehealth Hormone Options

Independent analysis examines Fridays' published TRT program structure, delivery format options, and what clinical research…

19 hours ago

How Does Ozempic Work For Weight Loss? Best Weight Loss Supplement Launch By PhenQ

Ozempic for Weight Loss: Does It Work and Is It Safe? Read PhenQ Details –…

19 hours ago

Best NAD+ Injection for 2026: Sprout Health Lists Compounded NAD+ at $149 First Month as Telehealth Longevity Programs Expand

Prescription NAD+ Injection Access, At-Home Administration Models, Compounding Standards, and What Consumers Should Know Before…

19 hours ago

Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options

Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…

2 days ago